EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Jan 29, 2019
Document Date
Jan 25, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
Filer
GUYER DAVID R
EyePoint Pharmaceuticals